← FDA DRUG APPROVALS

FDA ANDA · ANDA079014

ALFUZOSIN HYDROCHLORIDE

Sponsor: PHARMOBEDIENT

APPLICATION
ANDA079014
TYPE
ANDA
ORIGINAL APPROVAL
2011-07-18
LATEST ACTION
2022-09-23
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

ALFUZOSIN HYDROCHLORIDEDiscontinued
ALFUZOSIN HYDROCHLORIDE 10MG · TABLET, EXTENDED RELEASE · ORAL

Approval history

2022-09-23Labeling · Supplement 9 · standardAP
2018-11-14Labeling · Supplement 8 · standardAP
2015-01-13Labeling · Supplement 6 · standardAP
2011-07-18OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →